MEDP insider transaction filings
Medpace Holdings, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen MEDP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 15,609 @ $606.47 · Sale (S): 27,174 @ $618.79 | EDGAR |
| 2026-08-21 | 4 | DAVENPORT FRED B JR — Director | Option exercise (M): 1,903 @ $133.87 · Option exercise (M): 3,858 @ $84.36 · Option exercise (M): 1,822 @ $164.68 · Sale (S): 7,283 @ $606.15 · Option exercise (M): 1,903 (derivative) @ $0 · Option exercise (M): 3,858 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-21 | 4 | Carley Brian T — Director | Sale (S): 5,000 @ $608.63 | EDGAR |
| 2026-08-14 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 11,366 @ $601.53 · Sale (S): 458 @ $600.39 | EDGAR |
| 2026-08-13 | 4 | McCarthy Cornelius P. III — Director | Sale (S): 1,140 @ $605.37 | EDGAR |
| 2026-08-12 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 5,534 @ $601.53 · Sale (S): 17,610 @ $605.11 | EDGAR |
| 2026-08-11 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 3,858 @ $84.36 · Sale (S): 795 @ $585.07 · Option exercise (M): 3,858 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 3,728 @ $600.85 · Sale (S): 3,510 @ $600.01 | EDGAR |
| 2026-07-29 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Sale (S): 7,500 @ $600 | EDGAR |
| 2026-07-02 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 28 · Option exercise (M): 28 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Carley Brian T — Director | Option exercise (M): 36 · Option exercise (M): 36 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Kraft Robert O. — Director | Option exercise (M): 33 · Option exercise (M): 33 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 16,349 @ $138.87 · Sale (S): 16,349 @ $450 · Option exercise (M): 16,349 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Zander Dani S. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Gwadry-Sridhar Femida H. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | McCarthy Cornelius P. III — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Carley Brian T — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Kraft Robert O. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | DAVENPORT FRED B JR — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Brady Kevin M. — CFO & Treasurer | Option exercise (M): 7,000 @ $138.87 · Option exercise (M): 7,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 3,500 @ $138.87 · Option exercise (M): 3,500 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Troendle August J. — CEO, Director, 10% owner | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 29 · Option exercise (M): 29 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Carley Brian T — Director | Option exercise (M): 36 · Option exercise (M): 36 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Kraft Robert O. — Director | Option exercise (M): 33 · Option exercise (M): 33 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 12,000 @ $166.73 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | GEIGER JESSE J — President | Option exercise (M): 31,707 @ $138.87 · Sale (S): 31,707 @ $455.30 · Option exercise (M): 31,707 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 3,500 @ $138.87 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Carley Brian T — Director | Option exercise (M): 6,472 @ $54.99 · Option exercise (M): 6,472 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,984 @ $107.93 · Option exercise (M): 10,984 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 49 · Option exercise (M): 49 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Carley Brian T — Director | Option exercise (M): 62 · Option exercise (M): 62 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Kraft Robert O. — Director | Option exercise (M): 56 · Option exercise (M): 56 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,000 @ $107.93 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,000 @ $107.93 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 668 @ $590.69 | EDGAR |
| 2025-12-03 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 23,178 @ $593.25 · Sale (S): 5,698 @ $590.47 | EDGAR |
| 2025-12-02 | 4 | McCarthy Cornelius P. III — Director | Grant/award (A): 113 (derivative) @ $592.46 | EDGAR |
| 2025-12-02 | 4 | Carley Brian T — Director | Grant/award (A): 143 (derivative) @ $592.46 | EDGAR |
| 2025-12-02 | 4 | Kraft Robert O. — Director | Grant/award (A): 130 (derivative) @ $592.46 | EDGAR |
| 2025-12-01 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 41,331 @ $606.88 · Sale (S): 15,151 @ $593.46 | EDGAR |
| 2025-11-26 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Sale (S): 20,000 @ $609.15 | EDGAR |
| 2025-11-26 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 59,025 @ $607.78 · Sale (S): 42,392 @ $615.52 | EDGAR |
| 2025-11-25 | 4 | Brady Kevin M. — CFO & Treasurer | Option exercise (M): 3,000 @ $166.73 · Sale (S): 3,000 @ $590.35 · Gift (G): 170 @ $0 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 6,830 @ $598.49 · Sale (S): 21,858 @ $592.18 | EDGAR |
| 2025-11-20 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 7,191 @ $590.84 · Sale (S): 23,862 @ $592.07 | EDGAR |
| 2025-11-18 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 14,747 @ $595.26 · Sale (S): 6,047 @ $591 | EDGAR |
| 2025-11-18 | 4 | Kraft Robert O. — Director | Option exercise (M): 6,472 @ $54.99 · Sale (S): 6,472 @ $591.85 · Option exercise (M): 6,472 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 5,312 @ $603.23 · Sale (S): 5,128 @ $601.37 | EDGAR |
Recent 8-K events — Medpace Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-19 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MEDP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →